SOUTH SAN FRANCISCO, Calif. — Twist Bioscience (Nasdaq: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that it will exercise its option to purchase all rights to a G-coupled protein receptor (GPCR) library and its proprietary Twist Antibody Optimization (TAO) software, both developed […]
PROVIDES ACCESS TO PROVEN LUMINEX MULTIPLEXING TECHNOLOGY AND MOLECULAR TESTING SOLUTIONS TO BE USED IN UNIQUE TESTING PANELS, GENERATING CRITICAL MASS IN THE MOLECULAR DIAGNOSTICS SPACE SETS THE GROUND FOR NEW PARTNERSHIPS AND BUSINESS DEVELOPMENT OPPORTUNITIES THROUGH LIFE SCIENCE OFFERINGS BROADENS DIASORIN’S PRESENCE IN THE U.S. ACCELERATES LUMINEX TECHNOLOGY AND SOLUTIONS’ PENETRATION OUTSIDE THE U.S. […]
Abby is the next generation chemiluminescence Western protein analyzer and Stellar modules set the standard for fluorescence sensitivity MINNEAPOLIS — Bio-Techne Corporation (NASDAQ:TECH) today announced that ProteinSimple, a Bio-Techne brand, released Abby, its next generation chemiluminescence system that automates traditional Western blotting. This latest addition to the Simple Western product family offers picogram-level sensitivity through […]
SOUTH SAN FRANCISCO, Calif. — Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, has signed an agreement enabling multiple academic laboratories at Stanford University to access Twist Bioscience’s innovative antibody discovery and optimization services as well as its unique “Library of […]
Global distribution agreement with ABCAM plc to sell Avacta’s SARS-CoV-2 research ELISA Affimer reagents Cambridge, UK: Avacta Group plc (AIM: AVCT), the developer of innovative cancer therapies and diagnostics based on its proprietary Affimer® and pre|CISION™ platforms, is pleased to announce that it has entered into a global distribution agreement with ABCAM plc (AIM: ABC; NASDAQ: ABCM) […]
NEW YORK — NanoMosaic, the pioneer and leader in nanoneedle (MosaicNeedle™) detection for proteomics and genomics, has installed its end-user fully customizable, nanoneedle proteomic beta system, “Tessie™,” at its second test site, the New York Stem Cell Foundation Research Institute (NYSCF). Tessie™, is able to achieve seven orders of dynamic range interrogation at a competitive, […]
Genovis AB’s (publ) Chief Financial Officer (CFO) Johny Humaloja has resigned from his position to take on new challenges. Johny has been employed by Genovis since 2019 and he will continue in his current role during the notice period. A process to recruit a new CFO will be initiated immediately. “During his time at Genovis, […]
This certification further demonstrates NEB’s commitment to environmental stewardship, scientific advancement and social responsibility as a global life science leader. IPSWICH, MA — New England Biolabs (NEB®), a leader in the discovery and production of enzymes for molecular biology applications, today announced it has become a Certified B Corporation™ (B Corp™), joining a global community […]
Three new bio-layer interferometry (BLI) systems: Octet® R2 with 2-channels, Octet® R4 with 4-channels and Octet® R8 with 8-channels Field upgradeable to the higher channel system, providing the flexibility to expand based on throughput needs and budget Rapidly determine affinity, kinetics, and specificity of protein-protein and protein-small molecule interactions as well as measure protein concentrations in crude samples. […]
Transaction combines SomaLogic’s comprehensive proteomics technology platform with CM Life Sciences II, a leading life science-focused SPAC, led by affiliates of institutional investors Casdin Capital and Corvex Management. Combination is expected to provide up to $651 million in cash proceeds for SomaLogic, expanding the cash on its balance sheet to $686 million to catalyze organic […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
